Complement Component 4c

• Description:

  Complement Component 4c_x000D_ Catalog number: B2012214_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 100 ug_x000D_ Molecular Weight or Concentration: 147 kDa_x000D_ Supplied as: Solution_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: C4, Complement C4, C4c_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Press EM, Gagnon J. Human complement component C4. Structural studies on the fragments derived from C4b by cleavage with C3b inactivator Biochem J. 1981 Nov 1;199(2):351-7._x000D_ 2: Law SK, Gagnon J. The primary structure of the fourth component of human complement (C4)-C-terminal peptides Biosci Rep. 1985 Oct-Nov;5(10-11):913-21._x000D_ 3: Padilla-Docal B, Iglesias-González I, Bu-Coifiu-Fanego R, Socarrás-Hernández CA, Dorta-Contreras AJ. Intrathecal activation as a typical immune response within the central nervous system in angiostrongyliasis Am J Trop Med Hyg. 2013 Feb;88(2):230-5._x000D_ 4: Duan S, Sun L, Nie G, Chen J, Zhang C, Zhu H, Huang Z, Qian J, Zhao X, Xing C, Zhang B, Yuan Y. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes Front Immunol. 2020 Sep 2;11:2073._x000D_ 5: Ajona D, Remirez A, Sainz C, Bertolo C, Gonzalez A, Varo N, Lozano MD, Zulueta JJ, Mesa-Guzman M, C Martin A, Perez-Palacios R, Perez-Gracia JL, Massion PP, Montuenga LM, Pio R. A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer Transl Res. 2021 Jul;233:77-91._x000D_ 6: van der Kolk LE, Grillo-López AJ, Baars JW, Hack CE, van Oers MH. Complement activation plays a key role in the side-effects of rituximab treatment Br J Haematol. 2001 Dec;115(4):807-11._x000D_ 7: Goldstein R, Moulds JM, Sengar DP. A rare complement component C4 restriction fragment length polymorphism in two families with systemic lupus erythematosus J Rheumatol. 1991 Mar;18(3):345-8._x000D_ 8: Romi F, Kristoffersen EK, Aarli JA, Gilhus NE. The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo J Neuroimmunol. 2005 Jan;158(1-2):191-4._x000D_ 9: Molenaar ET, Voskuyl AE, Familian A, van Mierlo GJ, Dijkmans BA, Hack CE. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein Arthritis Rheum. 2001 May;44(5):997-1002._x000D_ 10: Kenawy HI, Ali YM, Rajakumar K, Lynch NJ, Kadioglu A, Stover CM, Schwaeble WJ. Absence of the lectin activation pathway of complement does not increase susceptibility to Pseudomonas aeruginosa infections Immunobiology. 2012 Feb;217(2):272-80. _x000D_ _x000D_ Products Related to Complement Component 4c can be found at Proteins

• Short Description:

  Catalog Number: B2012214 (100 ug)_x000D_ Complement Component 4c is a high quality human Complement Component 4c purified from Human Plasma. This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5